Tenderwize
Wróć do wyszukiwania

Dynamic Purchasing System for Pharmaceutical Products

Intercent-ER — Agenzia regionale per lo sviluppo dei mercati telematici·Bologna, Italy·EUR 15000M·Deadline Feb 24, 2028 · 549 days left·Restricted·Supplies·DPS
Zarejestruj się, aby zapisaćOpen documents
High value
Oryginalny tytuł ogłoszenia

Italy – Pharmaceutical products – Istituzione del Sistema Dinamico di Acquisizione per la fornitura di Beni Farmaceutici. Finalizzato alla partecipazione di Appalti specifici per la stipula di Convenzioni/Accordi quadro. Il SDA potrà.

60/100

Ocena szansy

Needs reviewMedium complexity
SuppliesDPSOpen
Skąd ta ocena?

Szansa

60 / 100

Złożoność

40 / 100

Czynniki ryzyka

Structured data indicates DPS duration of 132 months and EU-funded, but XML notice shows 96 months validity and no EU f...

No procurement documents were analyzed; eligibility, award criteria, and detailed requirements are unknown.

Restricted procedure — pre-qualification required

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • EUR 15000M estimated value
  • Dynamic Purchasing System (DPS)
  • Supplies contract
  • 1 lot
  • Duration 132 MONTH
  • Establishment of a Dynamic Purchasing System for pharmaceutical products
  • Specific contracts to be awarded via invitation to qualified suppliers
Pokaż pełne podsumowanie

Establishment of a Dynamic Purchasing System (DPS) for pharmaceutical products, usable by Intercent-ER and regional health authorities. Single lot (LOT-0000) with estimated value of €15 billion. The DPS has a duration of 132 months (per structured data) but XML notice indicates 96 months validity. Submission deadline is 2028-02-24. Inconsistencies exist in duration and EU funding flags. Procedure is restricted; language is Italian only.

Ryzyka

Structured data indicates DPS duration of 132 months and EU-funded, but XML notice shows 96 months validity and no EU f...

No procurement documents were analyzed; eligibility, award criteria, and detailed requirements are unknown.

Restricted procedure — pre-qualification required

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Admission to DPS via electronic request throughout its validity
  • Compliance with requirements specified in individual invitations

Administrative

  • Electronic submission only via the provided platform

Kryteria udzielenia

Lot 1

Award criteria not specified at DPS level; will be defined in specific contracts.

Zamawiający

Lokalizacja

Bologna, ITA

Profil zamawiającego

Otwórz profil

Identyfikator

0000246017

Działalność

General public services

Części (1)

LOT-0000

Dynamic Purchasing System for Pharmaceutical Products

Establishment of a DPS for the supply of pharmaceutical products. Specific contracts will be awarded via invitations, with detailed requirements per contract.

SuppliesDPSEU fundedElectronic submission

EUR 15B

Szacowana wartość

Lokalizacja

ITH55, Italy

Czas trwania

132 MONTH

Kategoria

Pharmaceutical products

Kryteria udzielenia

Award criteria not specified at DPS level; will be defined in specific contracts.

Termin

Deadline Feb 24, 2028

Szczegóły zamówienia

Data publikacji
24 Feb 2025
Języki
Italian

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
125860-2025

Dokumenty (2)

Dokument zamówienia 1Portal składania ofert 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3